Skandinaviska Enskilda Banken (SEB)
ADVM

Skandinaviska Enskilda Banken (SEB)’s Adverum Biotechnologies ADVM Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-790
Closed -$165K – 1023
2020
Q2 		$165K Buy
+790
New +$140K ﹤0.01% 929

Other funds holding ADVM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s ADVM Position: Q3 2020 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Adverum Biotechnologies (ADVM) in Q3 2020, closing a stake of 790 shares — an estimated $165K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ADVM in Q2 2020 and held it in 1 quarter. The position peaked at $165K in Q2 2020. 160 funds tracked by Wall St. Rank hold ADVM as of Q3 2020.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Adverum Biotechnologies position as of Q3 2020 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 790 Adverum Biotechnologies shares in Q3 2020, an estimated $165K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Adverum Biotechnologies in Q2 2020 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Adverum Biotechnologies position peaked at $165K in Q2 2020.
  • 160 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2020.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2020, filed 12 Nov 2020.